Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Fluorine-19 magnetic resonance imaging (19F MRI) is an imaging modality that detects the magnetic resonance (MR) signal from the fluorine-19 (^19F) nucleus, primarily in exogenously administered fluorinated compounds, such as perfluorocarbon-based probes or fluorinated drugs[1][4][6][7]. 19F MRI offers high specificity and quantification capabilities because endogenous fluorine is nearly absent in biological tissues, resulting in negligible background signal[1][4][8]. This technique enables noninvasive tracking and quantification of labeled cells, nanoparticles, or drugs in vivo, and has seen applications in cell tracking, immune monitoring, and drug distribution studies[2][3][4][6]. While 19F MRI is a powerful imaging technique, it is not itself a therapeutic target, enzyme, or receptor, and as such, entries like this are not considered valid molecular targets for drug discovery databases.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Fluorine-19 magnetic resonance imaging (19F MRI).